MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a common malignancy in China and Southeast Asia. Radiotherapy is the major treatment modality for patients with NPC, but does not always achieve fully satisfactory outcomes. Studies have shown that epidermal growth factor receptor (EGFR) is highly expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanyang, Li, Zhixi, Wu, Lu, Wang, Zi, Wang, Xia, Yu, Yang, Zhao, Qian, Luo, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973965/
https://www.ncbi.nlm.nih.gov/pubmed/24602316
http://dx.doi.org/10.1186/1475-2867-14-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973965/
https://www.ncbi.nlm.nih.gov/pubmed/24602316
http://dx.doi.org/10.1186/1475-2867-14-24

Ejemplares similares